109CADMIUM ABSORPTION EXCRETION AND TISSUE DISTRIBUTION FOLLOWING SINGLE TRACER ORAL AND INTRAVENOUS DOSES IN YOUNG GOATS

被引：49
|
作者：
MILLER, WJ
BLACKMON, DM
MARTIN, YG
机构：
来源：
JOURNAL OF DAIRY SCIENCE | 1968年 / 51卷 / 11期
关键词：
D O I：
10.3168/jds.S0022-0302(68)87287-X
中图分类号：
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号：
0905 ;
摘要：
引用
收藏
页码：1836 / &
相关论文
共 41 条
  • [31] A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans
    Schwab, Dietmar
    Portron, Agnes
    Backholer, Zoe
    Lausecker, Berthold
    Kawashima, Kosuke
    CLINICAL PHARMACOKINETICS, 2013, 52 (06) : 463 - 473
  • [32] A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans
    Dietmar Schwab
    Agnes Portron
    Zoe Backholer
    Berthold Lausecker
    Kosuke Kawashima
    Clinical Pharmacokinetics, 2013, 52 : 463 - 473
  • [33] A NOVEL DOUBLE-TRACER TECHNIQUE TO CHARACTERIZE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF ORAL [14C]VORASIDENIB AND CONCOMITANT INTRAVENOUS MICRODOSE ADMINISTRATION OF [13C315N3]VORASIDENIB IN HUMANS.
    Prakash, C.
    Yin, F.
    Le, K.
    Liu, H.
    Hassan, I.
    Lane, B.
    Yang, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S33 - S33
  • [34] ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF TROPIFEXOR, A POTENT FXR AGONIST FOR THE TREATMENT OF NASH, FOLLOWING A SINGLE ORAL 1 MG DOSE OF [14C]TROPIFEXOR IN HEALTHY MALE SUBJECTS
    Wang-Lakshman, Lydia
    Miao, Zhuang
    Gu, Jessie
    Choudhury, Subhajit
    McNamara, Elizabeth
    Walles, Markus
    Woessner, Ralph
    Camenisch, Gian
    Chen, Jin
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S76 - S76
  • [35] A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans
    Guerini, Elena
    Schadt, Simone
    Greig, Gerard
    Haas, Ruth
    Husser, Christophe
    Zell, Manfred
    Funk, Christoph
    Hartung, Thomas
    Gloge, Andreas
    Mallalieu, Navita L.
    XENOBIOTICA, 2017, 47 (02) : 144 - 153
  • [36] Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)]
    Sova, P
    Chladek, J
    Zak, F
    Mistr, A
    Kroutil, A
    Semerad, M
    Slovak, Z
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 288 (01) : 123 - 129
  • [37] A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
    Wollenberg, Lance
    Hahn, Erik
    Williams, Jason
    Litwiler, Kevin
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (05):
  • [38] Pharmacokinetics of ethylene glycol .2. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1(R) mice
    Frantz, SW
    Beskitt, JL
    Grosse, CM
    Tallant, MJ
    Dietz, FK
    Ballantyne, B
    XENOBIOTICA, 1996, 26 (11) : 1195 - 1220
  • [39] STUDIES ON METABOLISM OF D-ISOMERS AND L-ISOMERS OF 3,4-DIHYDROXYPHENYLALANINE (DOPA) .3. ABSORPTION DISTRIBUTION AND EXCRETION OF D-DOPA-C-14 AND L-DOPA-C-14 IN RATS FOLLOWING INTRAVENOUS AND ORAL ADMINISTRATION
    SHINDO, H
    NAKAJIMA, E
    KAWAI, K
    MIYAKOSHI, N
    TANAKA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1973, 21 (04) : 817 - 825
  • [40] A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV)
    Sova, Petr
    Mistr, Adolf
    Kroutil, Ales
    Semerad, Martin
    Chlubnova, Hana
    Hruskova, Veronika
    Chladkova, Jirina
    Chladek, Jaroslav
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1247 - 1256
12345